Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation x-rays

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 1, 2015, Pages 153-160

  Van Nimwegen, Frederika A ^a   Cutter, David J ^b,c   Schaapveld, Michael ^a   Rutten, Annemarieke ^a   Kooijman, Karen ^a   Krol, Augustinus D G ^d   Janus, Cécile P M ^e   Darby, Sarah C ^b   Van Leeuwen, Flora E ^a   Aleman, Berthe M P ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DOSIMETRY; ONCOLOGY; PATIENT MONITORING; RADIOTHERAPY; X RAYS;

CARDIAC COMPLICATIONS; CASE-CONTROL STUDY; CONFIDENCE INTERVAL; CORRECTION FACTORS; INTRACLASS CORRELATION COEFFICIENTS; METHODS AND MATERIALS; RADIATION FIELD; RADIOTHERAPY PLANNING;

HEART;

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ANALOG DIGITAL CONVERTER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; COHORT ANALYSIS; CONTROLLED STUDY; DOSIMETER; DOSIMETRY; FEMALE; HEART; HEART VOLUME; HODGKIN DISEASE; HUMAN; INTERRATER RELIABILITY; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MEAN HEART DOSE; MEDIASTINUM; MEDICAL RECORD REVIEW; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIOTHERAPY PLANNING SYSTEM; RADIOTHERAPY SIMULATOR; RETROSPECTIVE STUDY; TREATMENT PLANNING; X RAY; CASE CONTROL STUDY; LYMPH NODE; MIDDLE AGED; MORTALITY; OBSERVER VARIATION; ORGANS AT RISK; RADIATION RESPONSE; RADIOGRAPHY; REPRODUCIBILITY; SPLEEN; SURVIVOR; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HEART; HODGKIN DISEASE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; OBSERVER VARIATION; ORGANS AT RISK; RADIATION DOSAGE; REPRODUCIBILITY OF RESULTS; SPLEEN; SURVIVORS; YOUNG ADULT;

EID: 84927518249     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.02.019     Document Type: Article

References (35)

1. H.S. Kaplan Role of intensive radiotherapy in the management of Hodgkin's disease Cancer 19 1966 356 367
2. M. Tubiana, M. Henry-Amar, and P. Carde Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987 Blood 73 1989 47 56
3. H.T. Eich, V. Diehl, and H. Gorgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
4. A.E. Hay, B. Klimm, and B.E. Chen An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma Ann Oncol 24 2013 3065 3069
5. A.K. Ng, M.P. Bernardo, and E. Weller Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger J Clin Oncol 20 2002 2101 2108
6. L.B. Travis, A.K. Ng, and J.M. Allan Second malignant neoplasms and cardiovascular disease following radiotherapy J Natl Cancer Inst 104 2012 357 370
7. F.E. van Leeuwen, W.J. Klokman, and M.B. van 't Veer Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood J Clin Oncol 18 2000 487 497
8. B.M.P. Aleman, A.W. van den Belt-Dusebout, and M.L. De Bruin Late cardiotoxicity after treatment for Hodgkin lymphoma Blood 109 2007 1878 1886
9. M.C. Hull, C.G. Morris, and C.J. Pepine Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy JAMA 290 2003 2831 2837
10. A.K. Ng Review of the cardiac long-term effects of therapy for Hodgkin lymphoma Br J Haematol 154 2011 23 31
11. K. Gabriels, S. Hoving, and I. Seemann Local heart irradiation of apoe -/- mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis Radiother Oncol 105 2012 358 364
12. N.S. Russell, S. Hoving, and S. Heeneman Novel insights into pathological changes in muscular arteries of radiotherapy patients Radiother Oncol 92 2009 477 483
13. M.J. Adams, and S.E. Lipshultz Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: Implications for screening and prevention Pediatr Blood Cancer 44 2005 600 606
14. J.P. Veinot, and W.D. Edwards Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases Hum Pathol 27 1996 766 773
15. S.C. Darby, M. Ewertz, and P. McGale Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 2013 987 998
16. D.J. Cutter, M. Schaapveld, and S.C. Darby Risk of valvular heart disease after treatment for Hodgkin lymphoma J Natl Cancer Inst 2015 epub ahead of print
17. B.M. Aleman, E.C. Moser, and J. Nuver Cardiovascular disease after cancer therapy Eur J Cancer Suppl 12 2014 18 28
18. L.M. Morton, G.M. Dores, and R.E. Curtis Stomach cancer risk after treatment for Hodgkin lymphoma J Clin Oncol 31 2013 3369 3377
19. I. Diallo, A. Lamon, and A. Shamsaldin Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy Radiother Oncol 38 1996 269 271
20. B.M.P. Aleman, A.W. van den Belt-Dusebout, and W.J. Klokman Long-term cause specific mortality of patients treated for Hodgkin's disease J Clin Oncol 21 2003 3431 3439
21. M.L. De Bruin, J.A. Burgers, and P. Baas Malignant mesothelioma after radiation treatment for Hodgkin lymphoma Blood 113 2009 3679 3681
22. F.E. van Leeuwen, W.J. Klokman, and A. Hagenbeek Second cancer risk following Hodgkin's disease: a 20-year follow-up study J Clin Oncol 12 1994 312 325
23. P. Carde, J.M. Burgers, and M. Henry-Amar Clinical stages I and II Hodgkin's disease: A specifically tailored therapy according to prognostic factors J Clin Oncol 6 1988 239 252
24. H. Eghbali, J. Raemaekers, and P. Carde The EORTC strategy in the treatment of Hodgkin's lymphoma Eur J Haematol 75 2005 135 140
25. J. Raemaekers, H. Kluin-Nelemans, and I. Teodorovic The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer Eur J Cancer 38 Suppl. 4 2002 S107 S113
26. R. Somers, M. Tubiana, and M. Henry-Amar EORTC Lymphoma Cooperative Group studies in clinical stage I-II Hodgkin's disease 1963-1987 Recent Results Cancer Res 117 1989 175 181
27. M.C. Joiner, and A.J. Van der Kogel Basic Clinical Radiobiology 4th ed. 2009 Hodder Arnold London, United Kingdom
28. S.C. Darby, D.J. Cutter, and M. Boerma Radiation-related heart disease: Current knowledge and future prospects Int J Radiat Oncol Biol Phys 76 2010 656 665
29. C.A. Schneider, W.S. Rasband, and K.W. Eliceiri NIH image to ImageJ: 25 years of image analysis Nat Methods 9 2012 671 675
30. H. Levene Robust tests for equality of variances I. Olkin, S.G. Ghurye, W. Hoeffding, Contributions to Probability and Statistics 1960 Stanford University Press Stanford, CA 278 292
31. S.S. Shapiro, and M.B. Wilk An analysis of variance test for normality (complete samples) Biometrika 52 1965 591 611
32. P.E. Shrout, and J.L. Fleiss Intraclass correlations: Uses in assessing rater reliability Psychol Bull 86 1979 420 428
33. K.O. McGraw, and S.P. Wong Forming inferences about some intraclass correlation coefficients Psychol Methods 1 1996 30 46
34. D.V. Cicchetti Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Special section: Normative assessment Psychol Assessment 6 1994 284 290
35. A. Ng, K.K. Brock, and M.B. Sharpe Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: A step toward understanding dose risk for late toxicity Int J Radiat Oncol Biol Phys 84 2012 e557 e563